Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04639817 · ClinicalTrials.gov registry record
Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort Study
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 1,621
- Enrollment target
NCT04639817 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 1,621 participants.
The verdict
NCT04639817 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 1,621 participants
- Enrollment target
Study Summary
This study seeks to compare mortality outcomes of levofloxacin and trimethoprim-sulfamethoxazole treated patients who have Stenotrophomonas maltophilia blood stream or lower respiratory tract infections by retrospectively analyzing a propensity-matched cohort from a large dataset of electronic health record data.
Interventions
- DRUG trimethoprim-sulfamethoxazole
- DRUG Levofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,621 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2021-04-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04639817
The ClinicalTrials.gov registry entry for NCT04639817 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,621 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which trimethoprim-sulfamethoxazole is the first listed.
NCT04639817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04639817 about?
NCT04639817 is a clinical study titled "Trimethoprim-Sulfamethoxazole vs Levofloxacin as Targeted Therapy for Stenotrophomonas Maltophilia Infections: a Retrospective Cohort Study". This study seeks to compare mortality outcomes of levofloxacin and trimethoprim-sulfamethoxazole treated patients who have Stenotrophomonas maltophilia blood stream or lower respiratory tract infections by retrospectively analyzing a propensity-matched cohort from a large dataset of electronic healt...
What is the current status of trial NCT04639817?
This trial is currently completed. The enrollment target is 1,621 participants. The study started on 2020-08-14. Estimated completion is 2021-04-27.
What interventions are being tested in trial NCT04639817?
The interventions under investigation include: trimethoprim-sulfamethoxazole (DRUG), Levofloxacin (DRUG).
Who is sponsoring clinical trial NCT04639817?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.